The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies
Titel:
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies
Auteur:
McKay, Fiona C. Gatt, Prudence N. Fewings, Nicole Parnell, Grant P. Schibeci, Stephen D. Basuki, Monica A.I. Powell, Joseph E. Goldinger, Anita Fabis-Pedrini, Marzena J. Kermode, Allan G. Burke, Therese Vucic, Steve Stewart, Graeme J. Booth, David R.